Company: INSP
Filing Date: 2025-02-10
Form Type: 10-K
Source: 0001609550-25-000011
Chunk: 88

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-02-10
Form: 10-K
Item: Item 8
Chunk 88
---
.

Minneapolis, Minnesota

February 10, 2025 

89

Inspire Medical Systems, Inc.

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

December 31,20242023AssetsCurrent assets:Cash and cash equivalents$150,150 $185,537 Investments, short-term295,396 274,838 Accounts receivable, net of allowance for credit losses of     $880 and $1,648, respectively93,068 89,884 Inventories, net80,118 33,885 Prepaid expenses and other current assets12,074 9,595 Total current assets630,806 593,739 Investments, long-term70,995 9,143 Property and equipment, net71,925 39,984 Operating lease right-of-use assets23,314 22,667 Other non-current assets11,343 11,278 Total assets$808,383 $676,811 Liabilities and stockholders' equityCurrent liabilities:Accounts payable$38,687 $38,839 Accrued expenses49,814 39,266 Total current liabilities88,501 78,105 Operating lease liabilities, non-current portion30,039 24,846 Other non-current liabilities148 1,346 Total liabilities118,688 104,297 Commitments and contingencies (Note 12)Stockholders' equityPreferred Stock, $0.001 par value, 10,000,000 shares authorized;  no shares issued and outstanding— — Common Stock, $0.001 par value, 200,000,000 shares authorized;   29,740,176 and 29,560,464 shares issued and outstanding at   December 31, 2024 and 2023, respectively30 30 Additional paid-in capital981,043 917,107 Accumulated other comprehensive income536 800 Accumulated deficit(291,914)(345,423)Total stockholders' equity689,695 572,514 Total liabilities and stockholders' equity$808,383 $676,811 

The accompanying notes are an integral part of these financial statements.

90

Inspire Medical Systems, Inc.

Consolidated Statements of Operations and Comprehensive Income (Loss)

(in thousands, except share and per share amounts)

Year Ended December 31,202420232022Revenue